{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-088701","form_type":"8-K","ticker":"BJDX","cik":"0001704287","company_name":"Bluejay Diagnostics, Inc.","filed_at":"2026-08-13T11:56:27+00:00","discovered_at":"2026-08-13T12:00:03.539711+00:00","generated_at":"2026-08-13T12:00:08.524569+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bluejay completes SYMON-II enrollment of 750 patients; cash $9.6M, runway to Q2 2027","bullets":["Completed targeted enrollment of 750 patients in SYMON-II pivotal study for Symphony IL-6 test.","Cash and equivalents $9.6M at June 30, 2026 vs $5.2M at Dec 31, 2025; net proceeds $7.6M from June 2026 private placement.","Signed US manufacturing contract to mitigate supply-chain risk; advancing toward FDA 510(k) submission.","Cash estimated to fund operations through Q2 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-088701","json":"https://secwatch.observer/filing/0001213900-26-088701.json","markdown":"https://secwatch.observer/filing/0001213900-26-088701.md","text":"https://secwatch.observer/filing/0001213900-26-088701.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026088701/0001213900-26-088701-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026088701/ea0301888-8k_bluejay.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T12:00:08.524569+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}